Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

Innovative Binary Options Broker

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

4.74 0 (+0.00%)

7/22/2016  4:00pm

Open:

4.76

Pre. Close:

4.74

High:

4.80

Low:

4.70

Volume:

1,381,792

Market Cap:

467.92M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.86 - 4.95

4.95 - 5.05

Low:

4.49 - 4.57

4.57 - 4.64

Close:

4.6 - 4.76

4.76 - 4.91

Technical analysis  (as of: 2016-07-22 4:33:15 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 5.62     One year: 6.56

Support:

Support1: 4.37    Support2: 4.09

Resistance:

Resistance1: 4.81    Resistance2: 5.62

Pivot:

4.61

Moving Averages:

MA(5): 4.67     MA(20): 4.54

MA(100): 4.28     MA(250): 9.91

MACD:

MACD(12,26): 0.09     Signal(12,26,9): 0.07

%K %D:

%K(14,3): 83.24     %D(3): 76.61

RSI:

RSI(14): 56.99

52-Week:

High: 24.88  Low: 2.96  Change(%): -80.5

Average Vol(K):

3-Month: 2651  10-Days 1711

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CLDX has closed below upper band by 15.9%. Bollinger Bands are 79.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLDX's normal range. The bands have been in this narrow range for 82 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 07 Jun 2016 18:56:15 GMT
Why Celldex Therapeutics, Inc. Stock Rose 14.5% in May

Wed, 13 Jul 2016 21:00:00 GMT
5 Things Celldex Therapeutics, Inc. Wants You to Know

Fri, 29 Apr 2016 17:16:23 GMT
This One Drug Alone Makes Celldex Therapeutics, Inc. a Buy (Hint: It's not ...

Fri, 22 Jul 2016 13:41:15 GMT
Biotech Stocks Worth Chasing: Zafgen, Inc. (ZFGN), Celldex Therapeutics, Inc ...

Thu, 21 Jul 2016 13:52:30 GMT
This Hot Stock is Trending: Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

98.72

Shares Float (M)

98.15

% Held by Insiders

0.54

% Held by Institutions

89.20

Shares Short (K)

22140

Shares Short Prior Month (K)

25000

Stock Financials

EPS

-1.340

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

2.630

PEG Ratio

Profit Margin

Operating Margin

-2132.19

Return on Assets (ttm)

-23.6

Return on Equity (ttm)

-41.4

Qtrly Rev. Growth

168.1

Gross Profit (p.s.)

0.056

Sales Per Share

0.064

EBITDA (p.s.)

-1.319

Qtrly Earnings Growth

Operating Cash Flow (M)

-101.20

Levered Free Cash Flow (M)

-67.68

Valuation

P/E

-3.54

P/E Growth Ratio

P/BV

1.80

P/S

74.28

P/CF

-4.62

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.083

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.